Arcturus Therapeutics
ARCT
ARCT
139 hedge funds and large institutions have $694M invested in Arcturus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
22% less call options, than puts
Call options by funds: $6.57M | Put options by funds: $8.41M
52% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 44
Holders
139
Holding in Top 10
1
Calls
$6.57M
Puts
$8.41M
Top Buyers
| 1 | +$30.5M | |
| 2 | +$30.4M | |
| 3 | +$12.1M | |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$9.72M |
| 5 |
D.E. Shaw & Co
New York
|
+$7.62M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$12.1M | |
| 3 | -$7.87M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.92M |
| 5 |
Millennium Management
New York
|
-$4.34M |